Abstract IA016: Determinants of B cell fate and function in cancer
作者
Yuliya Pylayeva‐Gupta
出处
期刊:Cancer Research [American Association for Cancer Research] 日期:2022-11-15卷期号:82 (22_Supplement): IA016-IA016
标识
DOI:10.1158/1538-7445.panca22-ia016
摘要
Abstract Effector B cell responses in solid malignancies are associated with anti-tumor immunity and favorable response to immunotherapy. B cells can amplify anti-tumor immune responses through antibody production, antigen presentation, and pro-inflammatory cytokine release; yet B cells in cancer patients and tumor-bearing mice often fail to support these effector cell functions. The determinants of B cell fate and function in cancer are still not clear. We find that systemic exposure to STING agonists potentiates expansion of immunosuppressive regulatory human and mouse IL-35+ B lymphocytes in an IRF3 dependent manner. Mechanistically, the loss of STING signaling in B cells or treatment with cGAMP combined with ablation of IL-35 facilitates increases NK cell proliferation and enhances NK cell dependent anti-tumor response. Further, we identify dysregulated transcriptional programs activated in pancreatic cancer-associated B cells that promote differentiation of naïve into immunosuppressive B cells and inhibit differentiation of anti-tumor plasma cells. The signaling network that contributes to this dysfunction is driven by IL35-mediated formation of STAT3-PAX5 complex that upregulates the transcriptional factor BCL6 in B cells. Transient inhibition of BCL6 in naïve B cells is sufficient to stimulate the intratumoral accumulation of plasma cells and effector T cells and renders pancreatic tumors sensitive to anti-PD-1 immune checkpoint blockade therapy. Our findings reveal that systemic STING signaling can expand immunosuppressive B cells and show that B cell differentiation can be re-routed towards anti-tumor plasma cell response, suggesting novel combinatorial strategies to facilitate anti-tumor immune activity. Citation Format: Yuliya Pylayeva-Gupta. Determinants of B cell fate and function in cancer [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer; 2022 Sep 13-16; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2022;82(22 Suppl):Abstract nr IA016.